Judge Dismisses Lawsuit Against Iowa Medical Boards
A federal ruling upholds the legal immunity of state licensing boards following a physician's challenge.
Updated on Oct. 29, 2026 in COVID-19
Live Poll
Should professional licensing boards have absolute immunity when investigating claims of misconduct?
A federal judge has dismissed a lawsuit filed by former Iowa state senator and physician David Hartsuch against the state's medical and pharmacy boards. The court ruled that the legal action, which followed investigations into COVID-19 misinformation and off-label prescribing, was filed past the statute of limitations.
Why it matters
This ruling clarifies the legal protections afforded to state licensing boards when investigating professional misconduct. It reinforces the authority of medical boards to perform disciplinary reviews, as the court affirmed that members hold absolute immunity for their official actions.
A federal court ruling dismissed a lawsuit naming 21 defendants, citing that the complaint exceeded the state's two-year statute of limitations. The decision also noted that board members maintain absolute immunity regarding their disciplinary proceedings.
The players
David Hartsuch
An emergency medicine physician and former Iowa state senator who was the subject of medical board investigations.
Iowa Board of Medicine
The state regulatory agency responsible for investigating physician conduct and issuing professional licenses.
Stephen H. Locher
A federal judge who presided over the case and ruled on the statute of limitations and the immunity of board members.
The details
The disciplinary process began after the Iowa Board of Pharmacy received a complaint, prompting the Board of Medicine to investigate concerns over misleading COVID-19 information and off-label prescribing practices. Although the board initially issued a warning letter to Hartsuch in 2022, they later rescinded it in 2023. The judge determined that because the primary legal grievances occurred by mid-2023, the February 2026 filing fell outside the mandatory two-year window.
Timeline
October 2022: Board of Medicine issued a warning letter to Hartsuch.
July 2023: Board of Medicine rescinded the warning letter.
October 2025: Iowa Court of Appeals upheld a lower court ruling against Hartsuch.
February 2026: Hartsuch filed the federal lawsuit.
Health Landscape
This case sits within the broader regulatory effort to address medical misinformation during the pandemic, following the Iowa Board of Medicine's December 2021 investigation of 17 doctors. It reinforces the role of licensing boards in maintaining professional standards.
Patients concerned about clinical guidance or off-label prescribing should always discuss the scientific consensus behind their treatment plan with a physician. If you are unsure about the legitimacy of medical advice, cross-reference it with guidelines from the Iowa Board of Medicine.
The takeaway
Licensing boards are granted broad immunity to investigate professional conduct to ensure patient safety standards are met. Patients should be aware that physicians are held to strict regulatory oversight regarding the accuracy of the health information they provide.
Further reading
Learn more about local public health efforts and regulatory updates in Iowa COVID-19.
Source note: This article includes information reported by Iowacapitaldispatch.
Live Poll
Should professional licensing boards have absolute immunity when investigating claims of misconduct?
